Technology and Products
BioDiem is an Australian-based biotechnology company with a focus on developing and commercialising vaccine and infectious disease therapies.
The strength of our global partnering network is a key advantage of the Company. Our partners (the World Health Organisation and the US National Institutes of Health among others) are world-leading institutions that have in some cases facilitated our access to major markets (e.g. China and India).
Our strategy is to grow a diverse infectious disease treatment and prevention portfolio.
We currently earn revenue through licensing of LAIV influenza vaccine technology to Indian and Chinese partners.
For further information, please contact info@biodiem.com.
